Archived 47: Summary of National Advisory Committee on Immunization (NACI) updates of November 3, 2022: Recommendations on the use of Moderna Spikevax BA.4/5 bivalent mRNA (50 mcg) COVID-19 booster vaccine in adults

ASEM 文献综述

Official National Advisory Committee on Immunization document (2022) on “Archived 47: Summary of National Advisory Committee on Immunization (NACI) updates of November 3, 2022: Recommendations on the use of Moderna Spikevax BA.4/5 bivalent mRNA (50 mcg) COVID-19 booster vaccine in adults”. Summary of NACI updates on the use of Moderna Spikevax BA.4/5 bivalent mRNA COVID-19 booster vaccine in adults.

此摘要有助于您识别文档。对于临床建议，请始终查阅官方现行版本及其更新日期。